Stereotactic radiotherapy for prostate cancer with smaller margins
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a precise radiation treatment for prostate cancer that uses smaller safety margins to reduce side effects while still targeting the cancer effectively. It may be a good option for people with early-stage, low- or favorable intermediate-risk prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that is confirmed by biopsy and has not spread to lymph nodes or other parts of the body.
- Your cancer is classified as low risk or favorable intermediate risk according to NCCN guidelines.
- Your PSA level is 15 or lower.
- You are 18 years or older.
- You are willing and able to sign a consent form.
- You have not had radiation therapy to the pelvic area before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests a new way to deliver high-precision radiation to the prostate using daily MRI or CT scans to adjust the treatment based on your exact anatomy. It aims to make radiation more accurate and reduce side effects.
This trial tests a shorter radiation plan using an MRI machine to guide treatment. The goal is to see if two high-dose sessions work just as well as longer treatment, with fewer side effects. It is for men with low or intermediate risk prostate cancer.
This study tests a precise type of radiation (stereotactic radiotherapy) for men with early-stage prostate cancer. It aims to see if using custom radiation beams improves outcomes while reducing side effects.
This trial tests a precise, short-course radiation treatment (stereotactic body radiotherapy) after prostate removal surgery that adapts to your body each day to reduce side effects. It is for people whose prostate cancer has high-risk features or a rising PSA after surgery.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.